NCT04879030View on ClinicalTrials.gov

Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

December 30, 2020

Conditions
COPD Exacerbation Acute
Interventions
DRUG

Beta-Lactams

The patient was randomized to use beta-lactams antibiotic

DRUG

Fluoroquinolone

The patient was indicated to use a combination of beta-lactams and fluoroquinolones

Trial Locations (1)

18000

Haiphong International Hospital, Haiphong

All Listed Sponsors
lead

Haiphong University of Medicine and Pharmacy

OTHER

NCT04879030 - Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD | Biotech Hunter | Biotech Hunter